IRIS
SANTINI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 23.761
NA - Nord America 10.375
EU - Europa 4.421
SA - Sud America 1.902
AF - Africa 232
OC - Oceania 74
AN - Antartide 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 40.770
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 15.311
US - Stati Uniti d'America 9.945
CN - Cina 3.570
HK - Hong Kong 3.003
IT - Italia 2.007
BR - Brasile 1.406
GB - Regno Unito 787
VN - Vietnam 776
FR - Francia 651
IN - India 308
DE - Germania 291
AR - Argentina 213
CA - Canada 190
MX - Messico 160
ID - Indonesia 118
NL - Olanda 99
ZA - Sudafrica 96
BD - Bangladesh 89
TR - Turchia 83
JP - Giappone 78
FI - Finlandia 75
EC - Ecuador 72
UA - Ucraina 72
AU - Australia 67
PL - Polonia 63
CO - Colombia 55
SA - Arabia Saudita 54
ES - Italia 51
IQ - Iraq 51
PY - Paraguay 50
RU - Federazione Russa 50
PK - Pakistan 36
SE - Svezia 36
CL - Cile 35
CZ - Repubblica Ceca 34
UZ - Uzbekistan 32
PH - Filippine 31
PE - Perù 30
MA - Marocco 25
VE - Venezuela 22
EG - Egitto 21
MY - Malesia 21
BE - Belgio 19
CH - Svizzera 19
EE - Estonia 18
LT - Lituania 18
AZ - Azerbaigian 16
KR - Corea 15
NP - Nepal 15
DZ - Algeria 14
UY - Uruguay 14
ET - Etiopia 13
DO - Repubblica Dominicana 12
JM - Giamaica 12
KZ - Kazakistan 12
TH - Thailandia 12
AT - Austria 11
IL - Israele 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
BH - Bahrain 10
RO - Romania 10
TW - Taiwan 10
CR - Costa Rica 9
GR - Grecia 9
KE - Kenya 9
OM - Oman 9
PT - Portogallo 9
AL - Albania 8
BA - Bosnia-Erzegovina 8
GT - Guatemala 8
IE - Irlanda 8
KG - Kirghizistan 8
PS - Palestinian Territory 8
SI - Slovenia 8
HN - Honduras 7
HU - Ungheria 7
JO - Giordania 7
KH - Cambogia 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
SY - Repubblica araba siriana 7
BY - Bielorussia 6
KW - Kuwait 6
MD - Moldavia 6
NI - Nicaragua 6
DK - Danimarca 5
LB - Libano 5
AM - Armenia 4
BG - Bulgaria 4
BO - Bolivia 4
CY - Cipro 4
DM - Dominica 4
GA - Gabon 4
LA - Repubblica Popolare Democratica del Laos 4
LU - Lussemburgo 4
MN - Mongolia 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PA - Panama 4
Totale 40.678
Salva come PNG Salva come JPEG
Città #
San Jose 3.641
Hong Kong 2.981
Ashburn 2.488
Singapore 2.344
Rome 1.623
Hefei 1.389
Boardman 801
Beijing 699
London 672
Lauterbourg 593
Shanghai 485
Dallas 451
Ho Chi Minh City 260
Los Angeles 179
Hanoi 176
San Francisco 165
Council Bluffs 149
New York 137
São Paulo 137
Santa Clara 130
Pune 106
Seattle 102
Toronto 101
Munich 95
Mexico City 88
Washington 66
Tokyo 61
Warsaw 54
Rio de Janeiro 52
Amsterdam 50
Orem 46
Johannesburg 43
Brooklyn 40
Chennai 40
Frankfurt am Main 40
Turku 40
Montreal 39
Helsinki 35
Haiphong 34
Chicago 33
Melbourne 33
Da Nang 31
Tashkent 30
Brno 29
Milan 29
Belo Horizonte 28
Thái Bình 28
Biên Hòa 27
Boston 27
Stockholm 27
Riyadh 25
Buenos Aires 23
Quito 23
Asunción 22
Baghdad 21
Guayaquil 21
Naples 21
New Delhi 21
Jeddah 20
Manchester 20
Ribeirão Preto 20
Brasília 19
Curitiba 19
Lima 19
Phoenix 19
Secaucus 19
Atlanta 17
Campinas 17
Hangzhou 17
Bogotá 16
Canberra 16
Jakarta 16
Ninh Bình 16
Sydney 16
West Jordan 16
Ankara 15
Charlotte 15
Porto Alegre 15
Guangzhou 14
Istanbul 14
Addis Ababa 13
Hyderabad 13
Manaus 13
Mumbai 13
Paris 13
Salvador 13
St Louis 13
Baku 12
Caxias do Sul 12
Goiânia 12
Hanover 12
Hasselt 12
Bắc Giang 11
Cairo 11
Guarulhos 11
Joinville 11
Oklahoma City 11
Santo André 11
Sorocaba 11
Denver 10
Totale 21.744
Salva come PNG Salva come JPEG
Nome #
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 269
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 255
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 254
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 244
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 242
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 236
Early impairment of food intake in patients newly diagnosed with cancer 235
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer 233
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 231
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 231
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 231
Designing a broad-spectrum integrative approach for cancer prevention and treatment 231
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 230
A key opinion leader interview with Prof D Santini: insight into cancer research. 228
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 227
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 225
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 221
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 219
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 218
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 217
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 216
Premetastatic niche: ready for new therapeutic interventions? 215
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 214
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 214
Prevention of radiotherapy-induced emesis 214
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 212
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 212
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 211
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 210
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 209
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 208
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 205
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 203
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 201
Docetaxel induced pericardial effusion 200
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 197
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 196
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 194
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 190
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 176
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 166
A giant sarcoma of the parotid gland: A case report and review of the literature 160
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 153
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 152
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 146
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 139
'Old' and 'new' drugs for the treatment of cancer pain 137
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 136
Anestesia e malattie non comuni 136
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 135
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 135
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 133
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 133
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 132
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 129
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 129
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 129
Colorectal carcinomas and PTEN/MMAC1 gene mutations 125
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 125
Biological effects of cabozantinib on bone microenvironment 125
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 125
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 125
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 124
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 123
[Treatment of stage-I seminoma. Critical review] 122
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 121
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 121
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 120
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 120
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 119
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 118
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 115
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 115
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 115
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 114
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 114
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 114
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 113
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 113
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 111
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 111
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 110
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 109
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 109
Atypical chronic head and neck pain: don't forget Eagle's syndrome 109
Idiosyncratic reaction after oxaliplatin infusion 108
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature 108
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 108
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 107
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 104
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 101
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 100
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 100
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 98
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 97
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 96
Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study 94
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 92
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 90
A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients 90
Totale 15.932
Salva come PNG Salva come JPEG
Categoria #
all - tutte 323.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 323.095
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.008 0 4 5 8 73 10 15 4 42 20 23 804
2022/2023203 18 7 3 13 16 7 18 20 9 3 80 9
2023/20242.295 52 281 95 171 237 1.039 17 154 23 59 75 92
2024/202518.553 334 274 922 147 171 510 314 63 1.954 1.573 5.751 6.540
2025/202618.846 1.870 776 1.374 2.466 701 1.230 5.302 1.801 1.703 1.623 0 0
Totale 40.905